Scholars@Duke publication: Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial.

Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial.

Publication , Journal Article

Heller, JH; Spiridigliozzi, GA; Doraiswamy, PM; Sullivan, JA; Crissman, BG; Kishnani, PS

Published in: American journal of medical genetics. Part A

October 2004

American journal of medical genetics. Part A

1552-4825

October 2004

130

325 / 326

united states

APA

Chicago

ICMJE

MLA

NLM

Heller, J. H., Spiridigliozzi, G. A., Doraiswamy, P. M., Sullivan, J. A., Crissman, B. G., & Kishnani, P. S. (2004). Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial. American Journal of Medical Genetics. Part A, 130(3), 325–326.

Heller, J. H., G. A. Spiridigliozzi, P. M. Doraiswamy, J. A. Sullivan, B. G. Crissman, and P. S. Kishnani. “Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial.” American Journal of Medical Genetics. Part A 130, no. 3 (October 2004): 325–26.

Heller JH, Spiridigliozzi GA, Doraiswamy PM, Sullivan JA, Crissman BG, Kishnani PS. Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial. American journal of medical genetics Part A. 2004 Oct;130(3):325–6.

Heller, J. H., et al. “Donepezil effects on language in children with Down syndrome: results of the first 22-week pilot clinical trial.” American Journal of Medical Genetics. Part A, vol. 130, no. 3, Oct. 2004, pp. 325–26.

American journal of medical genetics. Part A

1552-4825

October 2004

130

325 / 326

united states